CS270143B1 - Coordination compounds and method of their preparation - Google Patents
Coordination compounds and method of their preparation Download PDFInfo
- Publication number
- CS270143B1 CS270143B1 CS884272A CS427288A CS270143B1 CS 270143 B1 CS270143 B1 CS 270143B1 CS 884272 A CS884272 A CS 884272A CS 427288 A CS427288 A CS 427288A CS 270143 B1 CS270143 B1 CS 270143B1
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- tsb
- denotes
- compounds
- scn
- alek
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title claims abstract description 18
- 238000000034 method Methods 0.000 title claims description 5
- 238000002360 preparation method Methods 0.000 title claims description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 8
- 239000000203 mixture Substances 0.000 claims description 6
- 239000010949 copper Substances 0.000 claims description 4
- 239000003446 ligand Substances 0.000 claims description 2
- SMQUZDBALVYZAC-UHFFFAOYSA-N salicylaldehyde Chemical compound OC1=CC=CC=C1C=O SMQUZDBALVYZAC-UHFFFAOYSA-N 0.000 claims 2
- HIOHRZIAENJDHP-UHFFFAOYSA-N CC(O)=O.N#CC#N Chemical compound CC(O)=O.N#CC#N HIOHRZIAENJDHP-UHFFFAOYSA-N 0.000 claims 1
- ALKZAGKDWUSJED-UHFFFAOYSA-N dinuclear copper ion Chemical class [Cu].[Cu] ALKZAGKDWUSJED-UHFFFAOYSA-N 0.000 claims 1
- 238000000855 fermentation Methods 0.000 claims 1
- 230000004151 fermentation Effects 0.000 claims 1
- XLJMAIOERFSOGZ-UHFFFAOYSA-M cyanate Chemical compound [O-]C#N XLJMAIOERFSOGZ-UHFFFAOYSA-M 0.000 abstract 2
- 241000721619 Najas Species 0.000 abstract 1
- 230000003115 biocidal effect Effects 0.000 abstract 1
- 239000005416 organic matter Substances 0.000 abstract 1
- ZMZDMBWJUHKJPS-UHFFFAOYSA-M Thiocyanate anion Chemical compound [S-]C#N ZMZDMBWJUHKJPS-UHFFFAOYSA-M 0.000 description 6
- 238000001228 spectrum Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 241001300571 Alaba Species 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 1
- 241000588722 Escherichia Species 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- ZPKQORGMNIHKAY-UHFFFAOYSA-K O.O.C(CC(O)(C(=O)[O-])CC(=O)[O-])(=O)[O-].[Cu+3] Chemical compound O.O.C(CC(O)(C(=O)[O-])CC(=O)[O-])(=O)[O-].[Cu+3] ZPKQORGMNIHKAY-UHFFFAOYSA-K 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 241000223238 Trichophyton Species 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 229940095731 candida albicans Drugs 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000003113 dilution method Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 150000004682 monohydrates Chemical class 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- ZHNFLHYOFXQIOW-LPYZJUEESA-N quinine sulfate dihydrate Chemical compound [H+].[H+].O.O.[O-]S([O-])(=O)=O.C([C@H]([C@H](C1)C=C)C2)C[N@@]1[C@@H]2[C@H](O)C1=CC=NC2=CC=C(OC)C=C21.C([C@H]([C@H](C1)C=C)C2)C[N@@]1[C@@H]2[C@H](O)C1=CC=NC2=CC=C(OC)C=C21 ZHNFLHYOFXQIOW-LPYZJUEESA-N 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Vynález ea týká keeriinačných zlú- . čenín typu.N-ealicylKén-^-alaniaáte-ti- •kyanát«Be4natanev vSeekecnéh· vzerca M[Cu(TSB)(SCN)J. χ H20 , alek· m2[cú(tsb)(scn)^1 . x h2o, kde M značí katiín alkallckéhe kevu alek· ΝΗΪ, TSB znaaená iianiín tr*J4«n*r·- ve j Schlff«vej záeaiy ·4ν·4βηβj ·< Z)-alanínu a saliijylaldehyiu a x = O, 1, 2 alek· 3} a sp»s»ku leh pripravy reakeiab! N-eallcyliién-/3-alaninát«Beinatýeh k«aplex«v zl«2enia[Cu2(TSB)2LJ. HgO ale- »i£Cu(TSB)LO. x H20, kie L značuje k*«rdinevaný je4n»4«nír*vý B«lekul»vy ligani, zvyčajne H20 a x - O, 1, 2 alek· 3, s ti*kyanatan*B vBe»kgcnéh· vz«rea.MSCN, ▼ kt«r«B M značí katlen alkallekéh· k«vu alek»zNH.. Zlúčeniny Bajú význaané antiBikrákné, najaS fungičíine vlaetneeti.The invention and the invention relates to kerinating compounds. n-ealicylKen - ^ - alaniaate-thiene • Cyanate «Beepataneous in the organic matter M [Cu (TSB) (SCN) J. χ H20, alk · m2 [cú (tsb) (scn) ^ 1. x h2o, where M denotes kain alkallke's kevu alek · ΝΗΪ, TSB marked iianiin tr * J4 «n * r · - in j l Schlff «ea iy ν ν ν ν ν ν ν ν ν ν ν ν ν β β β β β β β β β ní ní ní ní ní ní ní ní ní ní ní ní ní ní ní ní ní ní ní ní ní ní ní ní ní ní ní ní ní and saliijylaldehyium and x = 0, 1, 2 alek · 3} and s »k leh pripravy reakeiab! N-eallcyliién- / 3-alaninate 'Beinatýeh to "aplex" in [Cu 2 (TSB) 2 LJ. HgO ale- »I £ Cu (TSB) LO. x H20, kie L denotes k * «rdinevan je4n »4« nir * ex B «le llig y llig, usually H 2 O and x - 0, 1, 2 or 3, s ti * cyanate * B vBeCeReCeReRsMSCN, ▼ kt «r« B M denotes katlen alkallekéhk k vu alek »zNH .. Compounds Are Antibiotic najaS fungičine vlaetneeti.
Description
Vynález ea týká koordinaSných zlúSenín typu N-ealicylidén-/3-alanináto-tiokyanátomšinatanov vSeabecného vzercaThe present invention relates to coordinating compounds of the N-ealicylidene- (3-alaninato-thiocyanate) quinate type in the general formula
Mfcu(TSB)(SCN)D. x H20 , alabaMfcu (TSB) (SCN) D. x H 2 0, alaba
M2CCu(TSB)(SCN)p. x H2O kde M představuje katlán alkalického kevu, alebo NH^, TSB znamená dianión trojdonorovej Schiffevej zásady, «dvodemej edyý-alanínu a ealicylaldehydu (O.CgH^.CHoN.CHg.CHg.COO)2“ a x«0, 1, 2, alebo 3, ake aj spiseku přípravy týchto zlúSenín.M 2 CCu (TSB) (SCN) p. x H2O wherein M is an alkali Katlan kevu or NH ^, TSB represents a tridentate dianion Schiffevej base 'dvodemej Edyy -alanine and ealicylaldehydu (O.CgH .CHoN.CHg.CHg.COO ^) 2' and x '0, 1 , 2, or 3, as well as the preparation of these compounds.
Zlúčeninán pedla vynálezu sú podobné koordinaSné zlúčeniny typu N-salicylidén-®4-aminoalkaneáte-tiokyanátomeďnatanov (J. Krtttsmár-ŠmogroviS, V. Sereesová, t. QaSová, Š. Várkonda a V, KeneSnýi Se. autorské osvodSenie S. 265796, líšiace sa však tým, Se koordinuji TSB, odvedené odX-amlnokyoelín.The compounds of the invention are similar to the N-salicylidene-4-aminoalkaneate-thiocyanate-copper-coordinate compounds (J. Krtttsmár-ŠmogroviS, V. Sereesová, T. QaSová, Š. Várkonda and V, KeneSnýi. however, by coordinating TSB, they diverted from X-amlnokyoelin.
Známe sú tieS koordinaSné slúSeniny molekulového zloSenia, typu N-sál£dylidén-/$-alaninátomednatých komplexev vMeobecného vzerca ^Cu(TSB)IÍ3. x HgO, alek· CCu2(TSB)2lJ. HgÓ, kde TSB a x predstavujú to létá ake ve vsorcoch zlúSenín pedla vynálezu a L ·znaSuje koordinevanú melekulu HgO, aleke jednefunkSný molekulový ligand typu pyridinu, moSoviny, aleke tiomoSovlmy.Coordination compounds of the molecular composition, of the N-saltidylidene-β-alaninate type complex of the general formula (CuB) II, are also known. x HgO, alek · CCu 2 (TSB) 2 lJ. HgO, where TSB ax represents it, is as in all compounds of the present invention and represents a coordinated HgO molecule, but is a single-function molecular ligand of the pyridine, urea, or thiomosomal type.
Uvedené známe typy koordinaSných zlúSenín neďnatých majú ve viacarých případech význam ake jednoduché modely biologických syetémov, napr. metaloenzýnov a vykazujú aj antiaikrébna vlastnosti. Z nich N-aaljkcyliáén-^-alaninátamelnatá koaplaxy, slúSeniny aol«kul«vého zloSenia, sú takmer nerozpuetné vo vede, Se značné koaplikuja ich kielegické testovanie a aplikácie. N-Salicylldén-^-aainoalkanoáto-tiokyanátoaoinatany, které eú ▼· vede razpuetné, vykazujú zase ve vSaobecnostl nilSiu blologickú aktivitu aka porovnatelné zlúSeniny pedla vynálezu. .Said known types of coordinate compounds are important in several cases as simple models of biological systems, e.g. metalloenzines and also show anti-crab properties. Of these, N-alkanoyl-.alpha.-alaninate-ammonium coaplaxes, compounds of aloolytic composition, are almost insoluble in science, and their kegegal testing and applications are widely used. The N-salicylldene-4-aminoalkanoate-thiocyanatoanoates which are soluble in turn in turn generally show less biological activity than comparable compounds of the invention. .
V chemickéj literatúre nekalí d·teras opíeané zlúčeniny aeďnaté a dianiónmi N-salicylidén-^-alaninátového typu, ktaré viazanía SCN“ aka dalšieho aniónového Uganda vytvárajú kemplexn/ anlón, zloSku ve vede razpuetných seli zloSenia M[Cu(TŠB) (SCN)] , χ H20 , aleke m2[cu(tsb)(scň)2·]. χ h2o.In the chemical literature, dase terrified compounds of N-salicylidene-β-alaninate-type dianions, which bind to the SCN and another anionic Uganda do not form a camplex / anlone, a component in the M-Cu (SCN) (SCN) (SCN) , χ H 2 0, aleke m 2 [cu (tsb) (scň) 2 ·]. χ h 2 o.
Spisek přípravy koordinaSných zlúSenín epoSíva v reakciách prísluiných východiekových látek typu QCu2(TSB)2^]alebo(Cu(TSB)]0(uvedené ekratky vidy znanenajú to isté aka v predchádzajúcoa texte), pouSitých ve feno režných kryStalohydrátov, s nadbytkem MSCN v zaesiach etanelu a védy, pri teplotách 40 aS 70 *0. Po vychladnutí z raagujúcich sústav krystalizuji! zlúSoniny pedla vynálezu v dobrých výťaSkooh ake krystalické, zelen· efarbené produkty, velmi dobrého stupňa Sietoty.The description of the preparation of coordinating compounds is useful in the reactions of the corresponding starting materials of the type QCu 2 (TSB) 2 ^ or or (Cu (TSB)] 0 (the above abbreviations are the same as in the previous text), used in phenolic crystallite wastes, with an excess of MSCN in After cooling from the reactive systems, the compounds of the present invention crystallize in good yields as crystalline, green-colored products of a very good degree of crosslinking.
, Vybrané příklady ilustruji, ale noobmedzujú vieobocnú aetódu přípravy zlúSenín podlá vynálezu a charakterizuji ich sleleni·, ake aj niekteré vlastnosti a účinky. Okr·· výtažk»v, stanevenéh· «bsahu prvk»v (C, Η, N) a epektrálnej charakteristiky v tuhém skupenstva (technika nujelevých suspenzi!) na základe p»lehy abeerpSnéh· páea d-d prechadev va viditeýnej •blast! spektra, aa uvádza aj záletaná antinikrabdlna účinnost voSi Escherichia coll, Staphylococcus aureus, Candida albicans, Microsporun gypseun a Trichophyton torrostro, charakterizovaná mi.nimálneu inhibiSnou. koncentráciou (MIC v/Ug.cm~^) stanovenou diluSnou metodou. Zlstené hodnoty odpovedajú organizmem v aveděnom poradíš.The selected examples illustrate but limit the general method of preparation of the compounds of the invention and characterize their combination as well as some properties and effects. Extract of the solids of the element (C, Η, N) and the solid-state epectral characteristics (non-gaseous suspension technique!) spectra, and also shows the antimicrobial activity of Escherichia coll, Staphylococcus aureus, Candida albicans, Microsporun gypseun and Trichophyton torrostro, characterized by minimal inhibition. concentration (MIC v / Ug.cm ~ ^) determined by the dilution method. The hairy values correspond to the organism in the given order.
Příklad 1 ‘ 'Example 1 ‘'
5,45 g (Ό,ΟΪ mol) monohydrátu akva-bie(N-salicylidén-/J-alanináto)dimeďnatého komplexů sa rozpustí v 240 cm^ 75 £ etanelu pri teplota 60 *C, ta harúca přefiltruje a znieéa ea s roztěkán 6,1 g (0,08 mol) tlokyanatanu amonného v 40 cn^ vody tak, aby teplota raagujúcej súetavy bola 45 *C. Potom ea eúotava ochladí na 0 *0 a vylúSený seleno afarbený krystalický produkt ea po izolovaní na frlta přenyje ochládaným etanolom a usuší velne pri laboratorně j teplete. VýťaSok N-ealicylidén-/3-alanináto-tlokyanátomeiínatanu amonného je 75 %. Analýza. Pra C^HjjNjOjSCu, Mr 330,8 j vypačítané/zietenéi·35,93/39,85 £ 0 } 2,96/2,80 H ; 7,47/7,60 Ν. Elektránavé epektrun (VIS) s 1® 460 ca-1 . MIC j 600, 200, 700, 90, 200.5.45 g (Ό, ΟΪ mol) of aqua (N-salicylidene- (J-alaninato) disodium complex monohydrate are dissolved in 240 cm @ 3 of 75% ethanol at 60 DEG C., the mixture is filtered and dissolved. , 1 g (0.08 mol) of ammonium tocyanate in 40 cm 3 of water so that the temperature of the reactant system is 45 ° C. The mixture is then cooled to 0 DEG C. and the precipitated selenium-colored crystalline product ea, after isolation, is taken up in chilled ethanol and dried at room temperature. The yield of ammonium N-ealicylidene-β-alaninate-tocyanate monate is 75%. Analysis. Great HjjNjOjSCu C ^, M r 330.8 J vypačítané / zietenéi · 35.93 / 39.85 0} £ 2.96 / 2.80 H; 7.47 / 7.60 Ν. Electro-opening ectron (VIS) with 1® 460 ca -1 . MIC j 600, 200, 700, 90, 200.
CS 270 143 BlCS 270 143 Bl
Příklad 2Example 2
Pracevný pestup je ten istý ake v příklade 1 s tým rezdielem, že de reakcie sa peužije mieste tiekyanatanu aménnehe 7,8 g (0,08 mel) tiekyanatanu draeelnéhe. Výtažek N-aalicylidén^-alanináte-tiekyanátemednatanu draselnéhe je 79 %.The working step is the same as in Example 1, except that 7.8 g (0.08 ml) of potassium tecyanate are used in place of the reaction. The yield of potassium N-alicylidene-4-alanine tecyanate is 79%.
Analýza. Pre C-^HgNjO^SCuK, Mr = 351,9 ; vypečítané/zistené: 37,54/37,61 % C ; 2,58/2,73 % H i 7,96/8,14 % N. Elektrénevé spektrum (VIS): V^ = 14 7CO cm-1 . MIČ : 7CO, 200, 700, 90, 200.Analysis. For C 1 H 9 N 2 O 2 SCuK, M r = 351.9; calculated / found: 37.54 / 37.61% C; 2.58 / 2.73% H and 7.96 / 8.14% N. Electroelectric spectrum (VIS): λ = 14 7CO cm -1 . MIČ: 7CO, 200, 700, 90, 200.
Příklad 3Example 3
V zmesi 64 cn? etanelu a 8 cm^ vedy< sa rezpustí 5,45 g (0,01 mel) meněhydrátu akva-kis (N-salicyliién-$-alanináte)dimednatéhe kemplexu a přidá sa 6,48 g (0,08 mel) tiekyanatanu sednéhe. Reagujuca zmes sa za miefiania zahrieva na vadném kúpeli pri tepláte 70 *C až de rezpustenia tuhej fázy. Sústava sa za herúca přefiltruje a nechá vel'ne vychladnúť na laMeraternu tepletu. Z filtrátu vylúčené kryčtály tmavezelenej farky sa pe edsatí na frite premyjú 1 echladeným etanelem a usufiia veins pri lakeratérnej teplete. Výtažek dihydrátu N-ealicylidén-^-alanináte-kisítiekyanáte)meďnatanu disednéhe je 78 %.In a mixture of 64 cn? 5.45 g (0.01 ml) of aquacis (N-salicyliene-.alpha.-alaninate) menhydrate were dissolved in ethanol and 8 cm @ 3 of water and 6.48 g (0.08 ml) of sodium tecyanate were added. The reaction mixture is heated with stirring in a defective bath at a temperature of 70 DEG C. until the solid phase has dissolved. The system is filtered with a pellet and allowed to cool greatly on a laMeratern heat. The filtrate excluded kryčtály dark green Farkas pe edsatí the frit washed with 1 echladeným etanelem usufiia and veins of lakeratérnej teplete. The yield of N-ealicylidene-4-alaninate bisacyanate) copper citrate dihydrate is 78%.
k Analýza. Pre My = 452,9 $ vypečítané/zistené: 31,82/31,88 C ; 2,89/2,82 % H ; 9,28/9,20 % N. Elektrénevé spektrum (VIS) : VBax = 15 460 cm-1 . MIC =>1000, 200, 800, )1000, 200.k Analysis. For M y = $ 452.9 calculated / found: 31.82 / 31.88 C; 2.89 / 2.82% H; 9.28 / 9.20% N. Electrode spectrum (VIS): V Bax = 15 460 cm -1 . MIC => 1000, 200, 800,) 1000, 200.
phedmet vynálezu 'method of invention '
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CS884272A CS270143B1 (en) | 1988-06-20 | 1988-06-20 | Coordination compounds and method of their preparation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CS884272A CS270143B1 (en) | 1988-06-20 | 1988-06-20 | Coordination compounds and method of their preparation |
Publications (2)
Publication Number | Publication Date |
---|---|
CS427288A1 CS427288A1 (en) | 1989-08-14 |
CS270143B1 true CS270143B1 (en) | 1990-06-13 |
Family
ID=5385076
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CS884272A CS270143B1 (en) | 1988-06-20 | 1988-06-20 | Coordination compounds and method of their preparation |
Country Status (1)
Country | Link |
---|---|
CS (1) | CS270143B1 (en) |
-
1988
- 1988-06-20 CS CS884272A patent/CS270143B1/en unknown
Also Published As
Publication number | Publication date |
---|---|
CS427288A1 (en) | 1989-08-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Kovala-Demertzi et al. | Palladium (II) complexes of 2-acetylpyridine N (4)-propyl, N (4)-dipropyl-and 3-hexamethyleneiminylthiosemicarbazones with potentially interesting biological activity. Synthesis, spectral properties, antifungal and in vitro antitumor activity | |
Kaushal et al. | Synthesis of 2-acetylpyridine-N-substituted thiosemicarbazonates of copper (II) with high antimicrobial activity against methicillin resistant S. aureus, K. pneumoniae 1 and C. albicans | |
Kaushal et al. | Synthesis, structures, antimicrobial activity and biosafety evaluation of pyridine-2-formaldehyde-N-susbtituted-thiosemicarbazonates of copper (ii) | |
US3658788A (en) | Aminooxazolines and products thereof and processes for synthesizing same | |
CS270143B1 (en) | Coordination compounds and method of their preparation | |
SE443977B (en) | PROCEDURE FOR PREPARING 5 (6) -TIO-BENZIMIDAZOLDE DERIVATIVES | |
JPH03163055A (en) | Compound and complex particularly for use in forming medical image | |
Asman | Kinetics and mechanistic study of polynuclear platinum (II) polypyridyl complexes; A paradigm shift in search of new anticancer agents | |
Thompson et al. | Supramolecular metal helicate structures with incomplete metal ion coordination | |
Donald et al. | Synthesis of heterocycles from hydrogen cyanide derivatives | |
Alajrawy et al. | Dioxomolybdenum (VI) and oxomolybdenum (IV) complexes with N, O, and S bidentate ligands, syntheses, spectral characterization, and DFT studies | |
AA et al. | Mono and Trinuclear Complexes of α-Oximinoacetoacerylpyridine-4-phenylthiosemicarbazone | |
Kovala-Demertvi et al. | Compleves of 2, 4-diamino-5 (3', 4', 5'-trimethovybenvyl)-pyrimidine (trimethoprim) with platinum (II), rhodium (III) and gold (III) | |
Li et al. | Synthesis, Characterization, and Antimicrobial Studies of Copper (II), Nickel (II), and Zinc (II) Complexes with o-Methoxybenzaldehyde-2-Furan-Thiocarboxyhydrazone, 2-Furaldehyde-2-Furanthiocarboxyhydrazone, and 5-Nitro-2-Furaldehyde-2-Furanthiocarboxyhydrazone | |
Salameh et al. | Novel complexes of 2, 6-(dibenzothiazol-2-yl) pyridine and related ligands | |
Santra et al. | Chemistry of azopyrimidines. Part IV. Aromatic hydroxylation in palladium (II)-arylazopyrimidines | |
AKGEMCİ et al. | Determination of Thermodynamic Parameters of some Complexes of 9-ethyl-3-carbazolecarboxaldehyde 4-phenyl-3-thiosemicarbazone (ECCAPT) | |
Salih et al. | Vitamin B12 models: Synthesis and characterization of cyano bridged dicobaloximes and antimicrobial activity | |
Omotade et al. | Synthesis, Characterization And Antimicrobial Activity Of Mixed Ligand Complexes of Benzyliminothiosemicarbazide And L-Phenylalanine With Divalent Fe, Co and Ni | |
Verma et al. | Synthesis and spectral study of mixed ligand complexes of Chromium (III) dibasic tridentate schiff schiff bases as primary and naphthoic acid as co-ligand | |
Mir et al. | Synthesis and Conjoint Experimental-DFT Characterization of Some Pyrazolone Functionalized Dioxovanadium (V) Schiff Base Complexes | |
Alosaimi et al. | Green synthesis of thioxoimidazolidine derivative ligand: Spectroscopic, thermal and biological assignments of new Cu (II), Co (II), and Ni (II) chelates in neutral system | |
Ibrahim et al. | Synthesis, characterization and antimicrobial studies on Mn (II), Fe (II), Co (II) complexes of schiff base derived from 3-Formylchromone and Benzohydrazide | |
Prajapati et al. | Biochemical Studies on Some New Chelates of Co (II), Ni (II) and Cu (II) | |
Morgan et al. | Some Metal-Ion Complexes with Ligands Formed by Reactions of Amines with Aliphatic Carbonyl Compounds. VII. Copper (II) Compounds of Some β-Imino Amines, Formed by Reaction of Copper (II) Chelate Amine Complexes with 4-Amino-4-methylpentan-2-one |